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TriazineAbstract In the present study, new benzimidazole, benzoxazole and benzothiazole derivatives were
prepared and screened for antimicrobial activity. The structure of 4,40-((6-(4-(diethylamino)phenyl)-
1,3,5-triazine-2,4-diyl)bis(oxy))dibenzaldehyde (DIPOD) 5was established from p-hydroxy benzalde-
hyde 4 and 4-(4,6-dichloro-1,3,5-triazin-2-yl)-N,N-diethylaniline 3. The reaction ofDIPOD 5with dif-
ferent o-phenylenediamine or o-amino phenol or o-amino thiophenol in ethanol gave benzimidazole,
benzoxazole and benzothiazole 7. Novel heterocycles showed excellent broad-spectrum antimicrobial
activity against bacterial strain (Escherichia coli, Staphylococcus aureus) and fungal strain (Candida
albicans, Aspergillus niger) cultures. Activity data was compared with standard Streptomycin and
Fluconazole drug. Photophysical and thermal properties of synthesized compoundswere also studied.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.D license.1. Introduction
s-Triazine derivatives represent an important class of com-
pounds due to their potential to be biologically active. They
are known to be anti-protozoals (Balini et al., 2005), antican-
cer agents (Menicagli et al., 2004), estrogen receptor modula-
tors (Henke et al., 2002), antimalarials (Jensen et al., 2001;
Agarwal et al., 2005), cyclin-dependent kinase modulators
(Kuo et al., 2005), and antimicrobials (Koc et al., 2010. It
has been reported that s-triazine derivatives are used as tem-
plates for molecular imprinting (Tahmassebi and Sasaki,
1994) and for the construction of three-helix bundle protein
(Tahmassebi and Sasaki, 1998).
Synthesis of novel dipodal-benzimidazole, benzoxazole and benzothiazole from cyanuric chloride 263It is also important to note that compounds containing
benzimidazole, benzoxazole and benzothiazoles moieties often
exhibit diverse biological activities. These heterocycles are
known to have antibiotic (Evans et al., 1979), antiviral (Song
et al., 2005), anticancer (Kumar et al., 2002), and antimicrobial
(Yildiz-Oren et al., 2004) activities. These heterocycles have
also been used as ligands for complexes used in asymmetric
transformations (Figge et al., 2002). Benzimidazole derivatives
are an unique class of broad-spectrum antirhino/enteroviral
agents (Nakano et al., 2000), effective against the human cyto-
megalovirus (HCMV) (Zhu et al., 2000) and efﬁcient selective
neuropeptide YY1 receptor antagonists (Zarrinmayeh et al.,
1998).
In this paper, we have reported the novel benzimidazole,
benzoxazole and benzothiazole derivatives from 4,40-((6-(4-
(diethylamino)phenyl)-1,3,5-triazine-2,4-diyl)bis(oxy))dibenz-
aldehyde (DIPOD). The DIPOD was prepared by reacting
cyanuric chloride with N,N-diethyl aniline, followed by reac-
tion of 4-(4,6-dichloro-1,3,5-triazin-2-yl)-N,N-diethylaniline
with 2 equivalents of 4-hydroxybenzaldehyde. The compounds
are characterized by spectral analysis. Thermal properties and
antimicrobial activities of these compounds are studied.
2. Experimental
2.1. Materials and methods
All reagents and solvents were procured from s.d. ﬁne chemi-
cals (India) and were used without puriﬁcation. The reaction
was monitored by TLC using on 0.25 mm E-Merck silica gel
60 F254 precoated plates, which were visualized with UV light.
The FT-IR spectra were recorded on a Perkin–Elmer 257 spec-
trometer using KBr disks. 1H-NMR and 13C NMR spectra
were recorded on a VXR 400-MHz instrument using TMS as
an internal standard. Mass spectra were recorded on a Finni-
gan Mass spectrometer. The UV–visible absorption spectra
of the compounds were recorded on a Spectronic Genesys 2
UV–visible spectrophotometer. Simultaneous DSC-TGA mea-
surements were performed on SDT Q 600 v8.2 Build 100 mod-
el of Waters (India) Pvt. Ltd.
2.2. Biological activity
All compounds were evaluated for in vitro antibacterial activ-
ities against Escherichia coli and Staphylococcus aureus strains
and in vitro antifungal activity against Candida albicans and
Aspergillus niger strains by using serial dilution method.
2.2.1. General
Incubator at 35 and 37 C; pipettes of various sizes (Gilson);
sterile tips 5, 10, 50, 100, 200 lL sterile normal saline; sterile
isosensitest agar (Southern Group Laboratory, SGL); antibi-
otic solutions (Sigma–Aldrich); sterile solution of 10% (v/v)
DMSO in water (Sigma–Aldrich) were used for microbial
studies.
2.2.2. Medium
Isosensitest medium was used throughout the assay, as it is pH
buffered. Although NCCLS recommends the use of Mueller
Hinton medium for susceptibility testing, the isosensitest med-ium had comparable results for most of the tested bacterial
strains (Koeth et al., 2000).
2.2.3. Preparation of the plates
Plates were prepared under aseptic conditions. A sterile 96 well
plate was labeled. A volume of 100 lLof testmaterial in 10% (v/
v)DMSO (usually a stock concentration of 4 mg/mL)was pipet-
ted into the ﬁrst row of the plate. To all other wells, 50 lL of
nutrient broth was added. Serial dilutions were performed using
a multichannel pipette. Tips were discarded after use such that
each well had 50 lL of the test material in serially descending
concentrations. To each well, 10 lL of resazurin indicator solu-
tion was added, using a pipette of 30 lL strength isosensitized,
both added to each well to ensure that the ﬁnal volume was
the single strength of the nutrient broth. Finally, 10 lL of bacte-
rial suspension (5 · 106 cfu/mL) was added to each well to
achieve a concentration of 5 · 105 cfu/mL. Each plate was
wrapped loosely with cling ﬁlm to ensure that bacteria did not
become dehydrated. Each plate had a set of controls: a column
with a broad-spectrum antibiotic as positive control, a column
with all solutions with the exception of the test compound,
and a column with all solutions with the exception of the bacte-
rial solution, adding 10 lL of nutrient broth instead. The plates
were prepared in triplicate, and placed in an incubator set at
37 C for 18–24 h. The color change was then assessed visually.
Any color changes from purple to pink or colorless were re-
corded as positive. The lowest concentration at which color
change occurred was taken as the MIC value. The average of
three values was calculated and that was the MIC for the test
material and bacterial or fungal strain (Sarkar et al., 2007).
2.3. Synthesis of compounds
2.3.1. Synthesis of 4-(4,6-dichloro-1,3,5-triazin-2-yl)-N,N-
diethylaniline (3)
A mixture of N,N-diethylaniline (27 g, 0.2 mol) and cyanuric
chloride (18.4 g, 0.1 mol) was heated at 70 C for 8 h under a
slow stream of dry nitrogen, the reaction was monitored by
TLC, after completion the reaction mixture was extracted with
hot chloroform (200 mL) and the white crystals of hydrochlo-
ride salt of N,N-diethylaniline were removed by ﬁltration. Slow
cooling and evaporation of the chloroform extract to a volume
of 50 mL yielded good crystals of 3. The product was recrystal-
lized two times from acetone.
Yield: 11.68 g, 40%; m.p. (Crystallized from acetone)
156 C.
FT-IR (KBr) tmax cm
1: 824 (C–Cl), 1232 (C–N), 1515
(C‚N), 1610 (C‚C), 2967 (C–H).
1H NMR (400 MHz, CDCl3, 25 C) (d: ppm): 1.23 (t, 6H, –
CH3, J = 6.8, 7.2, 14.0, Hz), 3.46 (q, 4H, –CH2, J = 6.8, 7.2,
14.0, 14.4 Hz), 6.65–6.69 (dd, 2H, Ar–H, J= 9.2 Hz, 2.8 Hz),
8.29–8.33 (dd, 2H, Ar–H, J= 9.2, 2.8 Hz).
13C NMR (75 MHz, DMSOd6, 25 C) (d: ppm): 15.6,
49.0, 114.6, 125.6, 130.7, 154.2, 172.3, 179.5.
Mass: m/e = 298 (M++1), 299 (M++2).
2.3.2. 4,40-((6-(4-(Diethylamino)phenyl)-1,3,5-triazine-2,4-
diyl)bis(oxy))dibenzaldehyde (5)
p-Hydroxybenzaldehyde (4) (2.426 g, 0.022 mol) and 4-(4, 6-di-
chloro-1,3,5-triazin-2-yl)-N,N-diethylaniline (3) (3 g,
0.011 mol) were added to a suspension of K2CO3 (3.04 g,
264 V.S. Padalkar et al.0.022 mol) in 50 mL of benzene. The mixture was reﬂuxed for
22 h. The reaction mixture was then cooled and the solid was
removed by ﬁltration and washed with hot ethyl acetate twice.
The ﬁltrate was extracted with 10% Na2CO3 twice and with
H2O once. The organic layer was dried over anhydrous
Na2SO4 and then concentrated. The white powder was recrys-
tallized from 20 mL of ethyl alcohol to afford 3.31 g of 4,40-
((6-(4-(diethylamino)phenyl)-1,3,5-triazine-2,4-diyl)bis(oxy))
dibenzaldehyde (5) as a white ﬂuffy precipitate.
Yield: 3.31 g, 80%; m. p. (Crystallized from ethyl alcohol)
150 C.
FT-IR (KBr) tmax. cm
1: 1167 (–O– linkage), 1529 (C‚N),
1565 (C‚C), 1705 (Aldehyde Carbonyl C‚O), 2729 (Alde-
hyde C–H), 2929 (Methyl C–H stretch).
1H NMR (400 MHz, CDCl3, 25 C) (d: ppm): 1.19 (t, 6H, –
CH3, J = 6.7, 7.3, 14.3 Hz), 3.42 (q, 4H, -CH2, J = 6.7, 7.3,
13.9, 14.3 Hz), 6.58 (dd, 2H, J= 9.17, 2.71, Ar–H), 6.61 (dd,
2H, J= 9.17, 2.71, Ar–H), 7.41–7.44 (dd, 4H, J= 8.43,
1.83, Ar- H), 7.97-8.05 (dd, 4H, J= 8.80, 1.83, Ar–H), 10.04
(s, 2H, Aldehyde H).
13C NMR (75 MHz, DMSO-d6, 25 C) (d: ppm):12.3, 43.9,
110.7, 119.2, 122.5, 130.9, 131.1, 133.7, 151.5, 156.2, 171.53,
174.4, 192.9.
Mass: m/e = 469.2 (M+ + 1).
2.3.3. Synthesis of dipodal benzimidazole, benzoxazole and
benzothiazole from DIPOD
The dipodal benzimidazole, benzoxazole and benzothiazole (7)
were synthesized from DIPOD. To a stirring solution of DI-
POD (5) (0.5 g, 0.0011 mol) in ethanol, NaHSO3 (0.24 g,
0.0023 mol) in ethanol was added at room temperature. The
reaction mixture was treated with o-phenylenediamine
(0.25 g. 0.0023 mol) or m-nitrophenylenediamine (0.365 g,
0.0023 mol) or m-chloro-o-aminothiophenol (0.34 g,
0.0023 mol) or o-aminophenol (0.25 g, 0.0023 mol) in dimethyl
formamide (20 mL) and boiled under reﬂux. After 3 h, the con-
tent was poured into ice cold water (20 mL), the precipitate
formed was ﬁltered and recrystallized from ethyl alcohol.
2.3.3.1. Data for 7a. Yield: 0.67 g, 80%; m.p.: >168 C decom-
poses (Crystallized from ethyl alcohol).
FT-IR (KBr) tmax. cm
1: 1187 (–O– linkage), 1340 (C–N),
1552 (C‚N), 2926 (C–H), 3237 (NH).
1H NMR (400 MHz, CDCl3, 25 C) (d: ppm): 1.07 (t, 6H, –
CH3, J = 6.7, 7.3, 14.3 Hz), 3.30 (q, 4H, –CH2, J = 6.7, 7.3,
13.9, 14.3 Hz), 6.21 (d, 2H, NH), 6.47 (dd, 2H, J = 9.2,
8.6 Hz, Ar–H), 6.56 (dd, 2H, J = 9.2, 8.6 Hz, Ar–H), 7.09–
7.20 (dd, 4H, J = 2.4, 8.6 Hz, Ar–H), 7.43–7.52 (dd, 4H,
J = 9.2, 8.2 Hz, Ar–H), 7.79–7.86 (d, 4H, J = 8.2 Hz, Ar–
H), 8.14 -8.29 (d, 4H, J= 8.6 Hz, Ar–H).
13C NMR (75 MHz, DMSO-d6, 25 C) (d: ppm): 12.2, 43.8,
110.1, 119.3, 121.4, 122.9, 128.6, 129.3, 130.5, 131.7, 133.2,
152.4, 154.6, 157.3, 161.3, 170.2, 174.1, 175.0, 175.9.
Mass: m/e = 645.2 (M++1).
2.3.3.2. Data for 7b. Yield: 0.77 g, 76%; m.p.:>195 C decom-
poses (Crystallized from ethyl alcohol).
FT-IR (KBr) tmax cm
1: 1193 (–O– linkage), 1342 (–NO2),
1352 (C–N), 1559 (C‚N), 2925 (C–H), 3235 (NH).
1H NMR (400 MHz, CDCl3, 25 C) (d: ppm): 1.08 (t, 6H, –
CH3, J = 6.7, 7.3, 14.3 Hz), 3.31 (q, 4H, –CH2, J = 6.7, 7.3,13.9, 14.3 Hz), 6.28 (d, 2H, NH), 6.57 (d, 2H, J = 8.8 Hz,
Ar–H), 6.65 (d, 2H, J = 8.8 Hz, Ar–H), 7.13–7.29 (dd, 4H,
J = 2.2, 8.4 Hz, Ar–H), 7.46–7.57 (dd, 4H, J = 9.2, 8.5 Hz,
Ar–H), 7.84–7.89 (d, 4H, J = 8.5 Hz, Ar–H), 8.16–8.32 (m,
2H, J= 8.8 Hz, Ar–H).
13C NMR (75 MHz, DMSO-d6, 25 C) (d: ppm): 12.3, 43.9,
110.5, 119.3, 121.7, 122.6, 128.3, 130.8, 131.1, 133.7, 152.5,
154.3, 157.1, 161.7, 170.5, 174.7, 175.2, 176.0.
Mass: m/e = 737.5 (M++1).
2.3.3.3. Data for 7c. Yield: 0.85 g, 87%; m.p.: >200 C decom-
poses (Crystallized from ethyl alcohol).
IR (KBr) tmax cm
1: 808 (C–Cl), 1189 (–O–), 1566 (N‚N),
1670 (C‚C), 2971 (C–H).
1H NMR (400 MHz, CDCl3, 25 C) (d: ppm): 1.10 (t, 6H, –
CH3, J = 6.7, 7.3, 14.3 Hz), 3.34 (q, 4H, CH2, J = 6.7, 7.3,
13.9, 14.3 Hz), 6.36 (d, 2H, Ar–H), 6.67 (d, 2H, J = 8.2, Hz,
Ar–H), 6.89 (d, 2H, J = 8.2, Hz, Ar–H), 7.31–7.39 (dd, 4H,
J = 2.2, 8.2 Hz, Ar–H), 7.56–7.61 (dd, 4H, J = 9.4, 7.8 Hz,
Ar–H), 7.89–7.93 (d, 2H, J = 8.4 Hz, Ar–H), 8.32-8.39 (d,
2H, J= 9.2 Hz, Ar–H).
13C NMR (75 MHz, DMSO-d6, 25 C) (d: ppm): 12.4, 43.8,
110.3, 119.0, 121.4, 122.4, 122.9 128.3, 130.9, 131.4, 133.8,
152.2, 154.0, 157.4, 161.3, 170.3, 174.1, 175.6, 177.2.
Mass: m/e = 716.5 (M++1).
2.3.3.4. Data for 7d. Yield: 0.63 g, 74%; m.p.: >200 C decom-
poses (Crystallized from ethyl alcohol).
FT-IR (KBr) tmax. cm
1: 734 (C–S), 1192 (–O– linkage),
1352 (C–N), 1564 (C‚N), 2927 (C–H).
1H NMR (400 MHz, CDCl3, 25 C) (d: ppm): 1.08 (t, 6H, –
CH3, J = 6.7, 7.3, 14.3 Hz), 3.34 (q, 4H, –CH2, J = 6.7, 7.3,
13.9, 14.3 Hz), 6.71 (d, 2H, J= 7.3 Hz), 6.73 (d, 2H,
J= 7.3 Hz, Ar–H), 7.10–7.11 (d, 4H, J= 7.3 Hz, Ar–H),
7.27–7.33 (d, 4H, J= 7.3 Hz, Ar–H), 7.47–7.57 (dd, 4H,
J = 8.4, 7.7 Hz, Ar–H), 7.96–8.18 (dd, 4H, J= 8.4, 7.7 Hz,
Ar–H).
13C NMR (75 MHz, DMSO-d6, 25 C) (d: ppm): 12.4, 43.7,
110.0, 119.3, 121.3, 122.7, 123.9, 128.1, 130.7, 131.3, 133.1,
152.0, 154.3, 157.7, 161.1, 170.0, 174.1, 175.2, 177.1.
Mass: m/e = 679.2 (M++1).
3. Results and discussions
3.1. Chemistry
The synthetic route for DIPOD and its derivatives 7a–d is gi-
ven in Scheme 1. In 1H NMR spectra of DIPOD, the signal
was detected at about 10.04 ppm conﬁrming the formation
of DIPOD. Further conversion of DIPOD in dipodal deriva-
tives of benzimidazole, benzoxazole and benzothiazole were
conﬁrmed by 1H NMR and 13C NMR. Correlation was ob-
served between donor and acceptor properties of the group at-
tached to the benzimidazole, benzoxazole and benzothiazole
nucleus and chemical shift of the proton on each heterocycle.
3.2. Thermal stability
In order to examine the thermal stability of these compounds,
thermo gravimetric (TG) analysis was carried out between 40
and 600 C under nitrogen atmosphere. The TG curves of
Scheme 1 Synthesis of DIPOD derivatives 7a–d.
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that the frame work of the synthesized compounds is stable up
to 255 C. Above 255 C the thermo gravimetric curves of the
synthesized compounds showed loss in weight. The compari-
sons of the Td (decomposition temperature) showed that the
thermal stability of 7a–d decreases in the order
7b> 7c> 7a> 7d. Thermal stability and their plausible deg-
radation scheme were presented in Fig. 1.
3.3. Photophysical properties
To ﬁnd out the effect of benzimidazole, benzoxazole and ben-
zothiazole moieties as well as the communication between the
electron donating and acceptor termini on photophysical prop-
erties of dipodal derivatives, the UV–visible absorption and
emission spectra of DIPOD derivatives (7a–d) were recorded
in DMF at room temperature and the compound concentra-tion is 1 · 106 M. The kmax (absorbance) values of com-
pounds (7a–d) were obtained as 376, 383, 393 and 374 nm,
respectively Fig. 2 and kmax (emission) values of the com-
pounds 7a–d were obtained as 431, 429, 424 and 419 nm,
respectively Fig. 3. It is seen that the absorption-emission char-
acteristics of the compounds 7a–d are nearly same except the
fact that the intensities of emission showed some difference;
the compound 7c containing oxazole ring showed a slight
red shifted absorption.
Quantum yields of compounds 7a–d were determined by
using standard with known quantum yield (Anthracene).
Absorption and emission of standard as well as unknown sam-
ples were measured at different concentration of unknown
samples and standard (2 ppm, 4 ppm, 6 ppm, 8 ppm and
10 ppm). Graphs, absorbance intensity against emission inten-
sity were plotted for standard as well as unknown samples,
nature of the graph are straight line; Gradients were calculated
Figure 1 TGA analysis curves of 7a–d.
Figure 2 Absorption characteristics of compounds 7a–d.
Figure 3 Emission characteristics of compounds 7a–d.
266 V.S. Padalkar et al.for each compound and for standard. All the measurements
were done by keeping the parameters constant such as same
solvents and constant slit widths. Relative quantum yield of
all synthesized dipod derivatives 7a–d were calculated by using
Formula 1 (Williams et al., 1983).
UX ¼ USTðGradX=GradSTÞðg2X=g2STÞ
where UX is the quantum yield of unknown sample, UST the
quantum yield of standard used, GradX the Gradient of un-
known sample, GradST the gradient of standard used, g2X the
refractive index of solvent for standrad sample, g2ST the refrac-
tive index of solvent for sample.
The ﬂuorescence quantum yields of 7a–d are recorded in
ethanol at room temperature. It is observed that the values
of 7b and c in ethanol (0.197 for 7a, 0.0043 for 7b, 0.0179
for 7c and 0.1552 for 7d) were much lower than those recorded
for the 7a and d in the same solvent. Furthermore, as the










7a 376 431 55 0.1970
7b 383 429 46 0.0043
7c 393 424 31 0.0179
7d 374 419 45 0.1552
Table 2 Antimicrobial study of compounds 7a–d.
Strain Compounds
7a 7b 7c 7d
E. coli 62.5 62.5 62.5 125
S. aureus 250 125 62.5 125
C. albicans 62.5 250 62.5 250
A. niger 125 62.5 62.5 125
Streptomycin 125 125 – –
Fluconazole – – 125 125
Antimicrobial activity was expressed in MIC.
MIC: minimal inhibitory concentration values.
Bacterial strain: E. coli; S. aureus.
Fungal strain: C. albicans; A. niger.
Solvent used: DMSO (dimethyl sulfoxide).
Standard: Bacterial strain: Streptomycin 125 lg/mL, Fungal
strains: Fluconazole 125 lg/mL.
Synthesis of novel dipodal-benzimidazole, benzoxazole and benzothiazole from cyanuric chloride 267ﬂuorescence quantum yield of 7a and d was about 10 times
higher than that of 7b, all compounds showed similar ﬂuores-
cence behavior. The details are given in Table 1.
3.4. Biology
The novel compounds 7a–d were evaluated for their in vitro
antibacterial activity against E. coli and S. aureus strains and
in vitro antifungal activity against C. albicans and A. niger
strains by using the serial dilution method. The minimum
inhibitory concentration (MIC) value determined for com-
pounds showed signiﬁcant growth inhibition zone. The MIC
(lg/mL) values recorded in Table 2 indicate that most of the
tested compounds displayed variable inhibitory effects on the
growth of tested bacterial and fungal strains.
The compounds 7c showed good antibacterial activity
against E. coli and S. aureus strain and antifungal activity
against C. albicans and A. niger strain. On the other hand,
compounds 7a, b and d exhibited weak to moderate growth
inhibitory as revealed from their MIC values. Among these
compounds 7d showed relatively poor inhibitory activity
against both bacterial and fungal strains. Regarding the struc-
ture-activity relationship of the novel benzimidazole, benzox-
azole and benzothiazole derivative 7a–d against the tested
bacteria, the electron donating and electron withdrawing
groups in target molecules 7a–d affect the growth inhibitory
activity against tested bacterial strain. Compound 7c contain-
ing oxazole as electron withdrawing moiety is responsible to
enhance the microbial activity.
In general, the tested compounds showed better activity
against the bacterial strain (E. coli, S. aureus) and fungal strain
(C. albicans, A. niger). It would also be noticed thatcompounds containing oxazole gave better antibacterial and
antifungal activity than benzimidazole and benzothiazole com-
pounds. Antibacterial and antifungal activities of newly syn-
thesized compounds were indicated by MIC (lg/mL) value
using the modiﬁed resazurin assay.
4. Conclusions
Novel benzimidazole, benzoxazole and benzothiazole 7a–d
were synthesized; starting from cyanuric chloride 1 and for
their antimicrobial activities were studied. Overall observation
from the results of the antimicrobial activities of the synthe-
sized compounds revealed that the compound containing oxa-
zole nucleus is more active than imidazole and thiazole nucleus
over tested bacterial and fungal strain. Compounds showed
good thermal stability and photophysical properties with im-
proved quantum yield.References
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